-
Switching a medicinal ingredient from prescription to non-prescription...
This document includes guidance for companies (applicants) who wish to put forward submissions/applications to request a switch of an ingredient from prescription to non-... -
Food Directorate Update: Path Forward for Contaminants and Other...
Overview of Canadian guidelines on the acceptable maximum limits for various chemical contaminants in foods -
Directive on Physical Security Requirements for Controlled Substances and...
The following directive is intended to establish realistic minimum security standards for the storage of controlled substances as defined in the Controlled Drugs and Substances... -
Registration Decision RD2022-02, Beauveria bassiana strain CFL-A, Fraxiprotec
This decision is consistent with the Proposed Registration Decision PRD2021-10, Beauveria bassiana strain CFL-A, Fraxiprotec, which contains a detailed evaluation of the... -
Updated: Notice - Notification of Safety Labelling Changes to the Product...
Health Canada will continue to post a monthly table on the Department website which reflects updated and/or new safety information in PMs of brand name pharmaceutical drug... -
Healthy home guide
Every day, we are exposed to chemicals and pollutants in the air, water, soil, food and products we use in our home. Here are some tips on how to help protect yourself and those... -
Guidance on applications for drug clinical trials under the interim order: Overview
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process. -
Regulatory Directive: First Aid Labelling Statements
The purpose of this document is to communicate to industry and other interested parties, revisions to label statements addressing first aid measures in the event of accidental... -
Hyperbaric Oxygen Therapy
While hyperbaric oxygen therapy is recognized as an effective treatment for 14 specific conditions listed below, the operators of some private clinics claim it can also be used... -
Consumer Product Enforcement Summary Report: Cyclical Enforcement Project...
The purpose of this Cyclical Enforcement (CE) project was to verify industry's compliance of corded window covering products with specific requirements of the Corded Window... -
Benefits for companies participating in Canada's Access to Medicines Regime
Canada's Access to Medicines Regime is intended to address public health problems afflicting many developing and least-developed countries, especially those resulting from... -
Annex: About the Consumer Product Safety Program
Mission: Contribute towards a safe marketplace for consumer products and cosmetics by preventing, detecting and responding to adverse health occurrences to Canadians. -
Guidance Document - Human-Use Antiseptic Drugs
An antiseptic product is considered to be one that inactivates, reduces, prevents or arrests growth of microorganisms with the inherent intent to mitigate or prevent disease.... -
Transition Book for the Deputy Minister – Heath Canada
Deputy Minister Briefing Material – September 2019 - Overview of Health Canada as well as information on Governance and Operations. -
Reduce noise from consumer products
Some consumer products make noise loud enough to damage your hearing. -
Health Canada’s Proposal to Lower the Maximum Levels of Lead in Concentrated...
foods. These substances can either be inadvertently or naturally present in foods or, in some cases, intentionally added for fraudulent purposes. Establishing a prohibition or a... -
A guide to the new disaggregated data questionnaire for drug submissions
Health Canada uses disaggregated data to analyze the safety and efficacy of health products. The collection and analysis of disaggregated data in clinical trials is key to... -
Notice of Amendment: Tramadol removed from the Prescription Drug List (PDL)
The purpose of this Notice of Amendment is to notify that Health Canada has removed tramadol from the Prescription Drug List (PDL) and added it to Schedule I of the Controlled... -
Guidance Document: Part C, Division 5 of the Food and Drug Regulations...
This guidance document will help anyone who is involved in the conduct of clinical trials of drugs in humans to understand and comply with Part C, Division 5 of the Food and... -
Guidance Document - Quality (Chemistry and Manufacturing) Guidance: Clinical...
To assist submission sponsors in preparing Clinical Trial Applications (CTAs) filed with Health Canada by outlining the Quality (chemistry and manufacturing) technical...